<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01231880</url>
  </required_header>
  <id_info>
    <org_study_id>MCDC-SBMC</org_study_id>
    <nct_id>NCT01231880</nct_id>
  </id_info>
  <brief_title>School Based Malaria Control in Ugandan Schoolchildren</brief_title>
  <acronym>SBMC</acronym>
  <official_title>School-based Malaria Control: Impact of Intermittent Preventive Treatment on Malaria Morbidity and Cognitive Function in Ugandan School Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Makerere University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bill and Melinda Gates Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Makerere University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that schoolchildren treated with IPT using DP over one year of
      follow-up will have a different risk of clinical malaria compared to those treated with
      placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Risk of Clinical Malaria</measure>
    <time_frame>1 year</time_frame>
    <description>Fever(temperature greater or equal to 37.5 degrees centigrade or history of fever in past 24 hours) in presence of parasitemia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive function tests</measure>
    <time_frame>1 year</time_frame>
    <description>Mean score in the cognitive function tests (Raven's Matrices test and Code transmission test)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk of parasitemia</measure>
    <time_frame>1 year</time_frame>
    <description>presence of asexual parasites on blood smear</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of hospital admissions</measure>
    <time_frame>1 year</time_frame>
    <description>Admission of any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of adverse events</measure>
    <time_frame>1 year</time_frame>
    <description>Any untoward medical occurrence in a participant taking study medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>School performance</measure>
    <time_frame>1 year</time_frame>
    <description>Average position in class as reported in the end of the year school report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of anemia</measure>
    <time_frame>1 year</time_frame>
    <description>Proportion of hemoglobin measurements &lt; 10 g/dL.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">740</enrollment>
  <condition>Malaria</condition>
  <arm_group>
    <arm_group_label>Four monthly IPT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IPT give once a school term (every four months)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monthly IPT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IPT given every month</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No active drug in the placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Four monthly IPT with dihydroartemisinin Piperaquine (DP)</intervention_name>
    <description>Given every 4 months (once a school term)</description>
    <arm_group_label>Four monthly IPT</arm_group_label>
    <other_name>Duocortexin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Monthly IPT using DP</intervention_name>
    <description>Given every month</description>
    <arm_group_label>Monthly IPT</arm_group_label>
    <other_name>Duocortexin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo given every month</intervention_name>
    <description>No active ingredient</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 6 - 14 years

          -  Pupils enrolled at participating school

          -  Willingness of the parent/guardian to provide consent

          -  Provision of assent by pupil (those above 8 years)

        Exclusion Criteria:

          -  Known allergy or history of adverse reaction to study medications

          -  Intention of changing of schools during the follow-up period

          -  History (obtained from the parent/guardian) of any known serious chronic disease
             requiring frequent medical care
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaniter I Nankabirwa, MSc CEB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Makerere University Kampala</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mulanda Sub-district</name>
      <address>
        <city>Tororo</city>
        <zip>256</zip>
        <country>Uganda</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2010</study_first_submitted>
  <study_first_submitted_qc>October 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2010</study_first_posted>
  <last_update_submitted>May 22, 2013</last_update_submitted>
  <last_update_submitted_qc>May 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Makerere University</investigator_affiliation>
    <investigator_full_name>Faculty of Medicine</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Malaria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Piperaquine</mesh_term>
    <mesh_term>Dihydroartemisinin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

